Dr. Sandra Naffouj, MD is a physician provider in Orland Park, IL specializing in physician and gastroenterology (digestive system). She graduated from American University of Antigua in 2017 and has 9 years of experience. Dr. Sandra Naffouj, MD is affiliated with Northwestern Medicine and Northwestern Medical Group.
Dr. Sandra Naffouj, MD graduated from American University of Antigua in 2017. She completed residency at Henry Ford Health/Henry Ford Hospital. She is certified by the American Board of Internal Medicine/Gastroenterology - Gastroenterology (Certified) and has a state license in Illinois.
Medical School: American University of Antigua (2017)
Residency: Henry Ford Health/Henry Ford Hospital (2021)
Board Certification: American Board of Internal Medicine/Gastroenterology - Gastroenterology (Certified)
Licensed In: Illinois
Dr. Sandra Naffouj, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 36 ratings. We collect ratings and reviews of Dr. Sandra Naffouj, MD from all over the web to help you find the right in Orland Park, IL.
These charts describe general payments received by Dr. Sandra Naffouj, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Janssen Biotech, Inc. |
$288
Tremfya $288 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. |
$87
ENTYVIO $87 |
| Celltrion USA Inc. |
$66
VEGZELMA $66 |
| Food and Beverage | $441 |
|---|
Dr. Sandra Naffouj specializes in gastroenterology (digestive system) and physician and practices in Chicago, IL and Orland Park, IL. Dr. Naffouj speaks Arabic. Her areas of expertise consist of crohn's disease, microscopic colitis, and ulcerative colitis. She is affiliated with Northwestern Medical Group (NMG) and Palos Hospital. She attended American University of Antigua College of Medicine and then went on to complete her residency at Henry Ford Hospital. Dr. Naffouj's patients gave her an average rating of 5.0 stars (out of 5). Her practice in Orland Park, IL is open to new patients as reported by Yext.